Works about BLOOD coagulation factor VIII
Results: 1269
Association of bullous pemphigoid with acquired hemophilia A: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Acquired hemophilia A as a disease of the elderly: A comprehensive review of epidemiology, pathogenesis, and novel therapy.
- Published in:
- GeroScience, 2025, v. 47, n. 1, p. 503, doi. 10.1007/s11357-024-01317-7
- By:
- Publication type:
- Article
Avascular Villi, Increased Syncytial Knots, and Hypervascular Villi Are Associated with Pregnancies Complicated by Factor V Leiden Mutation.
- Published in:
- Pediatric & Developmental Pathology, 2010, v. 13, n. 5, p. 341, doi. 10.2350/09-05-0657-OA.1
- By:
- Publication type:
- Article
Phosphatidylserine Regulation of Coagulation Proteins Factor IXa and Factor VIIIa.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Coagulation assay of factor VIII activity in concentrates.
- Published in:
- Pharmaceutical Chemistry Journal, 2006, v. 40, n. 2, p. 112, doi. 10.1007/s11094-006-0071-1
- By:
- Publication type:
- Article
Accurate and cost‐effective prediction of HBsAg titer in industrial scale fermentation process of recombinant Pichia pastoris by using neural network based soft sensor.
- Published in:
- Biotechnology & Applied Biochemistry, 2019, v. 66, n. 4, p. 681, doi. 10.1002/bab.1785
- By:
- Publication type:
- Article
Purification of coagulation factor VIII by immobilized metal affinity chromatography.
- Published in:
- Biotechnology & Applied Biochemistry, 2015, v. 62, n. 3, p. 343, doi. 10.1002/bab.1276
- By:
- Publication type:
- Article
Sonic hedgehog and fibroblast growth factor 8 regulate the evolution of amniote facial proportions.
- Published in:
- Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-025-07522-0
- By:
- Publication type:
- Article
Evaluation of Protein S and Protein C Levels in B-Thalassemic Patients and Its Association with Blood Transfusion.
- Published in:
- Iraqi Journal of Cancer & Medical Genetics, 2020, v. 13, n. 1, p. 17, doi. 10.29409/ijcmg.v13i1.309
- By:
- Publication type:
- Article
Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.15698
- By:
- Publication type:
- Article
The effect of SARS‐Co‐V2 infection on prothrombotic and anticoagulant factors in dialysis patients.
- Published in:
- Artificial Organs, 2022, v. 46, n. 7, p. 1328, doi. 10.1111/aor.14206
- By:
- Publication type:
- Article
The effect of coagulation traits on the risk of retinal vein occlusion: a mendelian randomization study.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-87648-7
- By:
- Publication type:
- Article
Recent Advances in Gene Therapy for Hemophilia: Projecting the Perspectives.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 7, p. 854, doi. 10.3390/biom14070854
- By:
- Publication type:
- Article
Venous Thromboembolism and Cancer: A Comprehensive Review from Pathophysiology to Novel Treatment.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 2, p. 259, doi. 10.3390/biom12020259
- By:
- Publication type:
- Article
Caracterización clinicoepidemiológica de pacientes con hemofilia congénita de tipos A y B en Santiago de Cuba.
- Published in:
- MEDISAN, 2022, v. 26, n. 3, p. 54
- By:
- Publication type:
- Article
NXT007 does not interfere with the anticoagulant effects on tissue factor pathway inhibitor.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1435, doi. 10.1111/hae.15106
- By:
- Publication type:
- Article
Efficacy and safety of a recombinant von Willebrand factor treatment in acquired von Willebrand syndrome in case of bleeding and surgical procedures.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1341, doi. 10.1111/hae.15098
- By:
- Publication type:
- Article
Valoctocogene roxaparvovec gene therapy provides durable haemostatic control for up to 7 years for haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1138, doi. 10.1111/hae.15071
- By:
- Publication type:
- Article
Comprehensive laboratory assessment of lonoctocog alfa versus octocog alfa in severe haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1203, doi. 10.1111/hae.15089
- By:
- Publication type:
- Article
Bioclinical features of haemophilia patients in Benin in 2023: Towards better care.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1210, doi. 10.1111/hae.15082
- By:
- Publication type:
- Article
Efficacy of a 1:1 ratio VWF/FVIII concentrate in patients with von Willebrand disease.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1148, doi. 10.1111/hae.15079
- By:
- Publication type:
- Article
Emicizumab plasma levels after accelerated saturation in acquired haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1227, doi. 10.1111/hae.15069
- By:
- Publication type:
- Article
Recombinant FVIII replacement products for haemophilia A: An updated valuation by indirect comparison measuring area under the curve.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1230, doi. 10.1111/hae.15076
- By:
- Publication type:
- Article
Acquired haemophilia A in Finland: A nationwide study of incidence, treatment and outcomes.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1130, doi. 10.1111/hae.15037
- By:
- Publication type:
- Article
Evaluation of one‐stage and chromogenic assays for the laboratory measurement of factor VIII activity following valoctocogene roxaparvovec infusion.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1221, doi. 10.1111/hae.15064
- By:
- Publication type:
- Article
Reduced doses of emicizumab achieve good efficacy: Results from a national‐wide multicentre real‐world study in China.
- Published in:
- Haemophilia, 2024, v. 30, n. 4, p. 959, doi. 10.1111/hae.15062
- By:
- Publication type:
- Article
Estimated prophylactic dose required to achieve 3% trough as a function of age and concentrate class in multi‐country severe WAPPS‐Hemo haemophilia patients.
- Published in:
- Haemophilia, 2024, v. 30, n. 4, p. 925, doi. 10.1111/hae.15032
- By:
- Publication type:
- Article
Development of a Plasminogen Population PK model supporting prophylactic replacement therapy for Plasminogen deficient patients within the WAPPS‐Hemo platform.
- Published in:
- Haemophilia, 2024, v. 30, n. 4, p. 988, doi. 10.1111/hae.15027
- By:
- Publication type:
- Article
Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 4, p. 905, doi. 10.1111/hae.15025
- By:
- Publication type:
- Article
Classification of recombinant factor VIII products and implications for clinical practice: A systematic literature review.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 577, doi. 10.1111/hae.15001
- By:
- Publication type:
- Article
Genetic variant detection in a South African haemophilia B population.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 765, doi. 10.1111/hae.14978
- By:
- Publication type:
- Article
Current and emerging gene therapies for haemophilia A and B.
- Published in:
- Haemophilia, 2024, v. 30, p. 12, doi. 10.1111/hae.14984
- By:
- Publication type:
- Article
Haemophilia in the era of novel therapies: Where do inhibitors feature in the new landscape?
- Published in:
- Haemophilia, 2024, v. 30, p. 95, doi. 10.1111/hae.14982
- By:
- Publication type:
- Article
Benefits and risks of non‐factor therapies: Redefining haemophilia treatment goals in the era of new technologies.
- Published in:
- Haemophilia, 2024, v. 30, p. 39, doi. 10.1111/hae.14976
- By:
- Publication type:
- Article
Physical activity and factor VIII levels in patients with haemophilia: A real‐world prospective observational study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 419, doi. 10.1111/hae.14965
- By:
- Publication type:
- Article
Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 336, doi. 10.1111/hae.14963
- By:
- Publication type:
- Article
Canadian clinical experience on switching from standard half‐life recombinant factor VIII (rFVIII), octocog alfa, to extended half‐life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 345, doi. 10.1111/hae.14960
- By:
- Publication type:
- Article
Measurement of recombinant porcine factor VIII in patients with congenital haemophilia A and inhibitors in the presence of emicizumab.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 545, doi. 10.1111/hae.14955
- By:
- Publication type:
- Article
Unearthing the genotype‐inhibitor phenotype association in severe haemophilia A: A north Indian cohort study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 410, doi. 10.1111/hae.14948
- By:
- Publication type:
- Article
Peri‐operative desmopressin combined with pharmacokinetic‐guided factor VIII concentrate in non‐severe haemophilia A patients.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 355, doi. 10.1111/hae.14946
- By:
- Publication type:
- Article
Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 257, doi. 10.1111/hae.14944
- By:
- Publication type:
- Article
Health‐related quality of life of Indonesian children with hemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 463, doi. 10.1111/hae.14937
- By:
- Publication type:
- Article
Long‐term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post‐treatment.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 320, doi. 10.1111/hae.14936
- By:
- Publication type:
- Article
Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panel.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 306, doi. 10.1111/hae.14934
- By:
- Publication type:
- Article
Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single‐arm, open‐label study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 395, doi. 10.1111/hae.14932
- By:
- Publication type:
- Article
Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post‐marketing study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 388, doi. 10.1111/hae.14930
- By:
- Publication type:
- Article
Comparison of one‐stage and chromogenic factor VIII assays to tailor the dose of recombinant factor VIII‐Fc fusion protein (rFVIIIFc, efmoroctocog alfa) in adult patients with haemophilia A: Single‐centre, real‐world experience of surgery
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 538, doi. 10.1111/hae.14929
- By:
- Publication type:
- Article
Publication Only Abstracts.
- Published in:
- Haemophilia, 2024, v. 30, p. 189, doi. 10.1111/hae.14920
- Publication type:
- Article
Hybrid human‐porcine factor VIII proteins partially escape the inhibitory effects of anti‐factor VIII inhibitor alloantibodies having A2 or C2 domain specificity.
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 140, doi. 10.1111/hae.14911
- By:
- Publication type:
- Article
Unravelling the effect of blood group on FVIII:C levels and response to DDAVP in 20 males with a single genotype (Twillingate Variant) causing Haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 116, doi. 10.1111/hae.14896
- By:
- Publication type:
- Article